[DPHARMA] YoY Cumulative Quarter Result on 31-Dec-2020 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
22-Feb-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
31-Dec-2020 [#4]
Profit Trend
QoQ- 38.18%
YoY- 6.04%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 704,727 696,717 639,175 569,902 576,462 498,722 467,987 7.05%
PBT 63,267 84,851 82,983 76,157 70,809 59,666 51,796 3.38%
Tax -10,622 -14,739 -17,300 -17,547 -15,536 -12,025 -9,696 1.53%
NP 52,645 70,112 65,683 58,610 55,273 47,641 42,100 3.79%
-
NP to SH 52,645 70,112 65,683 58,610 55,273 47,641 42,492 3.63%
-
Tax Rate 16.79% 17.37% 20.85% 23.04% 21.94% 20.15% 18.72% -
Total Cost 652,082 626,605 573,492 511,292 521,189 451,081 425,887 7.35%
-
Net Worth 682,979 657,045 621,564 642,484 525,364 483,173 479,809 6.05%
Dividend
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Div 22,124 21,901 21,660 45,891 40,937 36,403 23,711 -1.14%
Div Payout % 42.03% 31.24% 32.98% 78.30% 74.06% 76.41% 55.80% -
Equity
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Net Worth 682,979 657,045 621,564 642,484 525,364 483,173 479,809 6.05%
NOSH 961,942 952,239 941,765 706,026 684,383 661,881 278,959 22.90%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 7.47% 10.06% 10.28% 10.28% 9.59% 9.55% 9.00% -
ROE 7.71% 10.67% 10.57% 9.12% 10.52% 9.86% 8.86% -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
RPS 73.26 73.17 67.87 80.72 84.49 75.35 167.76 -12.89%
EPS 5.49 7.39 6.98 8.46 8.25 7.26 15.09 -15.50%
DPS 2.30 2.30 2.30 6.50 6.00 5.50 8.50 -19.56%
NAPS 0.71 0.69 0.66 0.91 0.77 0.73 1.72 -13.70%
Adjusted Per Share Value based on latest NOSH - 706,026
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
RPS 73.21 72.37 66.40 59.20 59.88 51.81 48.61 7.06%
EPS 5.47 7.28 6.82 6.09 5.74 4.95 4.41 3.65%
DPS 2.30 2.28 2.25 4.77 4.25 3.78 2.46 -1.11%
NAPS 0.7095 0.6825 0.6457 0.6674 0.5457 0.5019 0.4984 6.05%
Price Multiplier on Financial Quarter End Date
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Date 29/12/23 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 -
Price 1.26 1.61 1.68 3.38 1.42 0.95 2.53 -
P/RPS 1.72 2.20 2.48 4.19 1.68 1.26 1.51 2.19%
P/EPS 23.02 21.87 24.09 40.72 17.53 13.20 16.61 5.58%
EY 4.34 4.57 4.15 2.46 5.70 7.58 6.02 -5.30%
DY 1.83 1.43 1.37 1.92 4.23 5.79 3.36 -9.62%
P/NAPS 1.77 2.33 2.55 3.71 1.84 1.30 1.47 3.14%
Price Multiplier on Announcement Date
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Date 22/02/24 23/02/23 15/02/22 22/02/21 13/02/20 18/02/19 28/02/18 -
Price 1.21 1.65 1.60 3.42 1.64 1.03 2.97 -
P/RPS 1.65 2.26 2.36 4.24 1.94 1.37 1.77 -1.16%
P/EPS 22.11 22.41 22.94 41.20 20.24 14.31 19.50 2.11%
EY 4.52 4.46 4.36 2.43 4.94 6.99 5.13 -2.08%
DY 1.90 1.39 1.44 1.90 3.66 5.34 2.86 -6.58%
P/NAPS 1.70 2.39 2.42 3.76 2.13 1.41 1.73 -0.29%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment